Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority study (ARGON)
Under an Elsevier user license
open archive
Keywords
Indacaterol/glycopyrronium/mometasone
Salmeterol/fluticasone
Tiotropium
AQLQ
Non-inferiority
Lung function
Cited by (0)
© 2020 Elsevier Ltd.